|Slideshows|April 23, 2019

Looking Ahead: Tardive Dyskinesia Care

Recent studies and reviews report great progress in bringing TD under control.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

ByKim Do, PhD,Jessica Walters

June 3rd 2026

New Analysis of BXCL501 At-Home Administration Shows Reduction of Agitation in Bipolar and Schizophrenia

ByJessica Walters

May 29th 2026

Engaging With Patients With Acute Psychosis: A Conversation With Peter J. Weiden, MD

ByJohn J. Miller, MD,Peter J. Weiden, MD

May 26th 2026

schizophrenia_Generative AI_AdobeStock_762900677 Person with schizophrenia

World Schizophrenia Awareness Day: Why Curiosity and Lived Experience Matter in Serious Mental Illness Care

ByTracy Hicks, DNP, FNP/PMHNP-BC,Heidi Anne Duerr, MPH

May 24th 2026

Psychotherapy and the Prevention of Relapse in Schizophrenia

ByMark L. Ruffalo, MSW, DPsa,Trisha M. Ruffalo, MSW

May 21st 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Looking Ahead: Tardive Dyskinesia Care

Related Content

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

New Analysis of BXCL501 At-Home Administration Shows Reduction of Agitation in Bipolar and Schizophrenia

Engaging With Patients With Acute Psychosis: A Conversation With Peter J. Weiden, MD

World Schizophrenia Awareness Day: Why Curiosity and Lived Experience Matter in Serious Mental Illness Care

Psychotherapy and the Prevention of Relapse in Schizophrenia

Latest CME

Southern California Psychiatry Conference

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Trending on Psychiatric Times

FDA Issues CRL for CTx-1301 for Treatment of ADHD

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

New Name, New Path for Psychiatry: The Future of the DSM

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy

Endangered Education: Psychiatric Professional Degrees Under Attack